208 results on '"Pittman, Phillip R."'
Search Results
2. Mpox Virus in Pregnancy, the Placenta, and Newborn: An Emerging Poxvirus With Similarities to Smallpox and Other Orthopoxvirus Agents Causing Maternal and Fetal Disease
3. Contributors
4. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition
5. Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in healthy research laboratory workers
6. Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
7. Rudolf Hess – The Doppelgänger conspiracy theory disproved
8. Mpox (Monkeypox) in Pregnancy: Viral Clade Differences and Their Associations with Varying Obstetrical and Fetal Outcomes
9. Design and Optimization of a Monkeypox virus Specific Serological Assay
10. Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in otherwise healthy research laboratory workers operating in containment laboratories
11. Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
12. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
13. Safety and immunogenicity of ricin vaccine, RVEc™, in a Phase 1 clinical trial
14. Contributors
15. Biodefense and Special Pathogen Vaccines
16. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response
17. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease
18. Monkeypox and pregnancy: correspondence
19. Chapter 13 - Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)
20. Anthrax vaccine adsorbed: Further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed
21. Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo.
22. Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo
23. 97 - Influenza Virus: A Public Health Concern
24. 95 - Severe Acute Respiratory Syndrome and Coronavirus Disease 2019
25. 91 - Tularemia
26. 90 - Anthrax
27. The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection
28. Management Guidelines for Laboratory Exposures to Agents of Bioterrorism
29. Analysis of Adverse Events after Anthrax Immunization in US Army Medical Personnel
30. Immunologic Interference from Sequential Administration of Live Attenuated Alphavirus Vaccines
31. An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals
32. Transcriptional profiling of recall responses to Francisella live vaccine strain
33. List of Contributors
34. Biodefense and special pathogen vaccines
35. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination
36. The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
37. Monkeypox and pregnancy: correspondence
38. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series
39. Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): Comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells
40. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
41. Retrospective Analysis of Pneumonic Tularemia in Operation Whitecoat Human Subjects: Disease Progression and Tetracycline Efficacy
42. Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects
43. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination
44. Long-term health effects of repeated exposure to multiple vaccines
45. 12 - Biodefense and Special Pathogen Vaccines
46. Contributors
47. Anthrax Vaccine: Evidence for Safety and Efficacy Against Inhalational Anthrax
48. Aluminum-containing vaccine associated adverse events: role of route of administration and gender
49. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid
50. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.